UKE Names Pioneering Cardiac Surgeon as New Heart Surgery Chief
UKE Names Pioneering Cardiac Surgeon as New Heart Surgery Chief
UKE Names Pioneering Cardiac Surgeon as New Heart Surgery Chief
The University Hospital Hamburg-Eppendorf (UKE) has appointed Prof. Dr. Evaldas Girdauskas as the new head of its clinic for heart and vascular surgery. He takes over from Prof. Dr. Dr. Hermann Reichenspurner, who led the department for years and will now serve in an advisory role. Girdauskas brings a strong focus on minimally invasive techniques and advanced surgical innovation to the position.
Prof. Girdauskas arrives at the UKE with a distinguished career in cardiac surgery. He has performed and led robot-assisted procedures, including aortic and mitral valve operations, at renowned institutions like Leipzig Heart Center and Toronto General Hospital. His expertise spans complex interventions, with a particular emphasis on faster recovery through minimally invasive methods and ERAS (Enhanced Recovery After Surgery) protocols.
His research background is equally impressive. With over 800 scientific publications, Girdauskas has earned national and international recognition for his work in transplantation medicine and cardiovascular care. His studies concentrate on population-based and biomarker-driven approaches, aiming to refine personalised treatment strategies for heart patients. At the UKE, he plans to build a cutting-edge heart surgery programme. This will include the full range of modern cardiac procedures, with a special push for robot-assisted techniques. The goal is to offer tailored, patient-focused care while maintaining the department's reputation for excellence in complex surgeries. Prof. Reichenspurner, the outgoing head, leaves a lasting legacy in heart-lung transplantation and minimally invasive surgery. His contributions helped shape the UKE's cardiac department into a leading centre for advanced cardiovascular medicine.
Prof. Girdauskas will now lead the UKE's heart and vascular surgery team, introducing new surgical technologies and personalised treatment plans. His appointment follows a long career marked by innovation in cardiac care. Meanwhile, Prof. Reichenspurner remains involved as an advisor, ensuring continuity in the department's strategic development.
Russian court orders forced TB treatment for man refusing care
When a man with deadly tuberculosis refused treatment, Russian authorities took drastic action. The ruling exposes gaps in handling infectious disease outbreaks.
Renowned Immunocardiologist Leads Charité's Heart Center Amid Major Expansion
A pioneer in immunocardiology steps into a pivotal role at Europe's largest heart center. His vision could redefine how inflammation shapes cardiovascular treatment.
Dexcom's 20% revenue surge fuels stock rally and European market dominance
A diabetes tech leader breaks records with sensor sales and market share. Why investors are betting big on Dexcom's global growth.
UKE Names Pioneering Cardiac Surgeon as New Heart Surgery Chief
A new era begins for Hamburg's top heart center. Can cutting-edge robotics and tailored therapies redefine recovery for cardiac patients?